VITASPRING BIOMEDICAL CO. LTD. VSBC
OTC · stock · Services-Commercial Physical & Biological Research · website · IPO 2019-10-01
VITASPRING BIOMEDICAL CO. LTD. statistics & valuation
Market cap$2.3M
Market cap as of 2026-07-02. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | 36.8% | 45.2% | 11.2% | 79.8% | 69.9% | — |
| Operating margin | — | — | — | — | 20.1% | 171.4% | 45.7% | -130.4% | -39.3% | — |
| Net margin | — | — | — | — | 16.2% | 171.4% | 45.7% | -130.4% | -39.3% | — |
| FCF margin | — | — | — | — | -6.1% | — | — | — | — | — |
| Return on assets | -2830.3% | -5389.6% | -814.4% | -543.7% | 25.2% | 224.6% | 3.7% | — | -340.1% | — |
| Return on equity | 9.4% | 19.3% | 33.4% | 173.8% | 57.7% | 441.4% | — | 323.7% | 186.4% | -1.5% |
| Current ratio | 0.00 | 0.00 | 0.01 | 0.14 | 1.76 | 2.04 | 2.04 | 0.55 | 0.68 | 2.85 |
Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.